Pharmacokinetics and effects on plasma retinol concentrations of 13-cis-retinoic acid in melanoma patients.

about

Induction of cell cycle arrest and apoptosis by a combined treatment with 13-cis-retinoic acid, interferon-alpha2a, and alpha-tocopherol in squamous cell carcinoma of the head and neck.

P2860

Q40197618-C709D599-B148-416F-8D03-D0C078405847

P2860

Pharmacokinetics and effects on plasma retinol concentrations of 13-cis-retinoic acid in melanoma patients.

Item

http://www.wikidata.org/entity/Q36431563

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh

1997年學術文章

@zh-hant

name

Pharmacokinetics and effects o ...... oic acid in melanoma patients.

@ast

Pharmacokinetics and effects o ...... oic acid in melanoma patients.

@en

type

Item

label

Pharmacokinetics and effects o ...... oic acid in melanoma patients.

@ast

Pharmacokinetics and effects o ...... oic acid in melanoma patients.

@en

prefLabel

Pharmacokinetics and effects o ...... oic acid in melanoma patients.

@ast

Pharmacokinetics and effects o ...... oic acid in melanoma patients.

@en

P1476

Pharmacokinetics and effects o ...... oic acid in melanoma patients.

@en

P2093

E Cavadini

http://www.w3.org/2001/XMLSchema#string

F Belli

http://www.w3.org/2001/XMLSchema#string

F Formelli

http://www.w3.org/2001/XMLSchema#string

L Mascheroni

http://www.w3.org/2001/XMLSchema#string

N Cascinelli

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.

Anti-proliferative activity of natural interferon-alpha, isotretinoin and their combination varies in different human melanoma cell lines.

Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats.

Metabolism of oral 9-cis-retinoic acid in the human. Identification of 9-cis-retinoyl-beta-glucuronide and 9-cis-4-oxo-retinoyl-beta-glucuronide as urinary metabolites.

13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.

13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.

Food increases the bioavailability of isotretinoin.

Pharmacokinetics of isotretinoin following a single oral dose.

P2888

bjc.1997.613

P304

1655-1660

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1997.613

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1997-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13816210

http://www.w3.org/2001/XMLSchema#string

P698

9413958

http://www.w3.org/2001/XMLSchema#string

P932

2228192

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetics and effects on plasma retinol concentrations of 13-cis-retinoic acid in melanoma patients.

about

P2860

P2860

Pharmacokinetics and effects on plasma retinol concentrations of 13-cis-retinoic acid in melanoma patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932